A Randomized Phase Ii Trial of Everolimus and Letrozole or Hormonal Therapy in Women with Advanced, Persistent or Recurrent Endometrial Carcinoma: A Gog Foundation Study

AuthID
P-00V-ZQF
12
Author(s)
Taub M.C.
·
Finkelstein K.A.
·
Moroney J.W.
·
Fleury A.C.
·
Muller C.Y.
·
Holman L.L.
·
Copeland L.J.
·
Coleman R.L.
Document Type
Article
Year published
2022
Published
in Gynecologic Oncology, ISSN: 0090-8258
Volume: 164, Issue: 3, Pages: 481-491 (10)
Indexing
Publication Identifiers
Pubmed: 35063278
Scopus: 2-s2.0-85123122581
Source Identifiers
ISSN: 0090-8258
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.